Actress Sana Makbul returns to work after a brief break with a women-oriented web series that highlights resilience, emotions ...

From protein portions to your daily coffee count, hepatologist Dr Cyriac Abby Philips revealed 6 strategies to maintain liver ...

The FDA has granted accelerated approval of Wegovy® (semaglutide) for adults with moderate to advanced metabolic ...

New research highlights a significant link between metabolic dysfunction-associated steatotic liver disease (MASLD), formerly ...

Rates of chronic liver disease during pregnancy are rising partly due to MASLD and the downward trend of chronic viral hepatitis.

Women with cirrhosis and ascites experience worse health-related quality of life (HRQoL) than men, although no difference is seen in daily function, according to a study published in the August issue ...

Statins reduce cirrhosis risk in a dose- and age-dependent manner. A daily dose equivalent to ≥20 mg simvastatin (or >40 mg for <54 years) appears effective, regardless of formulation. Independent ...

Dr Kolawole Akande, a consultant gastroenterologist at the University College Hospital (UCH) in Ibadan, in this interview with SADE OGUNTOLA, explains excessive fat in the liver as a dangerous ...

The ML-based model offers a noninvasive, accurate tool for individualized risk stratification and follow-up planning in patients with HBV-related cirrhosis and SPSS after initial endoscopic therapy.

The U.S. Food and Drug Administration approved the obesity drug Wegovy for people with the chronic liver disease known as ...

Epidemiological data on bacterial infections in cirrhosis in China remain limited. Therefore, we aimed to conduct a multicenter study to investigate the characteristics and outcomes of patients with ...

In patients with hepatocellular carcinoma (HCC), hyponatremia is an independent predictor of increased rates of in-hospital mortality, with a greater impact reported among those with cirrhosis, ...